Items where Author is "Beck, K."

2017

Heitz, U. and Cherbuin, J. and Menghini-Müller, S. and Egloff, L. and Ittig, S. and Beck, K. and Andreou, C. and Studerus, E. and Riecher-Rössler, A.. (2017) Comorbidities in patients with an at-risk mental state and first episode psychosis. In: Abstract of the 25th European Congress of Psychiatry, 41, Supplement. Florence.

Ittig, S. and Studerus, E. and Heitz, U. and Menghini-Müller, S. and Egloff, L. and Beck, K. and Leanza, L. and Andreou, C. and Riecher-Rössler, A.. (2017) Estradiol production suppressed by prolactin in at-risk mental state and first episode psychosis female patients? In: Abstract of the 25th European Congress of Psychiatry, 41, Supplement. Florence, S267.

Uttinger, M. and Rapp, C. and Studerus, E. and Beck, K. and Riecher-Rössler, A.. (2017) Stigma in early detection of psychosis: Subjective experiences of those concerned. In: Abstract of the 25th European Congress of Psychiatry, 41, Supplement. Florence, S387.

Leanza, L. and Egloff, L. and Studerus, E. and Andreou, C. and Heitz, U. and Beck, K. and Menghini-Müller, S. and Ittig, S. and Riecher-Rössler, A.. (2017) The relationship between negative symptoms and cognitive functioning in patients with an at-risk mental state for psychosis. In: Abstract of the 25th European Congress of Psychiatry, 41, Supplement. Florence, S270-S271.

Egloff, L. and Lenz, C. and Studerus, E. and Heitz, U. and Menghini-Müller, S. and Harrisberger, F. and Ittig, S. and Beck, K. and Leanza, L. and Andreou, C. and Riecher-Rössler, A. and Borgwardt, S.. (2017) Verbal learning and memory in at-risk mental state and first episode psychosis patients and their correlates to brain structural alterations. In: Abstract of the 25th European Congress of Psychiatry, 41, Supplement. Florence, Italy, S103.

2010

Ihnen, M. and Köhler, N. and Kersten, J. F. and Milde-Langosch, K. and Beck, K. and Höller, S. and Müller, V. and Witzel, I. and Jänicke, F. and Kilic, E.. (2010) Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases. DIS MARKERS, 28 (2). pp. 71-78.